Perspectives: what we are learning from factor XI/factor XIa inhibitor trials

Melissa F. Glasner, Jeffrey I. Weitz, Rasha Al-Lamee, María Cecilia Bahit, Jonathan M. Coutinho, S. Claiborne Johnston, David Gailani, Carolyn S.P. Lam, Tzu-Fei Wang, Wolfgang C. Winkelmayer

doi:10.1016/j.rpth.2026.106936

CrossrefInfo card

Perspectives: what we are learning from factor XI/factor XIa inhibitor trials

Melissa F. Glasner, Jeffrey I. Weitz, Rasha Al-Lamee, María Cecilia Bahit, Jonathan M. Coutinho, S. Claiborne Johnston, David Gailani, Carolyn S.P. Lam, Tzu-Fei Wang, Wolfgang C. Winkelmayer

Research and Practice in Thrombosis and Haemostasis · 2026-09 · 10 · 106936

DOI: 10.1016/j.rpth.2026.106936 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Melissa F. Glasner, Jeffrey I. Weitz, Rasha Al-Lamee, María Cecilia Bahit, Jonathan M. Coutinho, S. Claiborne Johnston, David Gailani, Carolyn S.P. Lam, Tzu-Fei Wang, Wolfgang C. Winkelmayer
Journal: Research and Practice in Thrombosis and Haemostasis
Year of publication: 2026
Volume / Issue: 10
Pages: 106936
Publisher: Elsevier BV
DOI: 10.1016/j.rpth.2026.106936
ISSN: 2475-0379
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.